Ally Bridge Group (NY) LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Ally Bridge Group (NY) LLC held in its portfolio 16 assets valued at $95,990,877 (i.e. $95.99M).

The most valuable assets in the portfolio included: REPLIMUNE GROUP INC ($11.66M), EDGEWISE THERAPEUTICS INC ($11.04M), and ABIVAX SA ($9.44M).

The chart below shows the top 10 valuable assets, and the table below shows the top 16 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Ally Bridge Group (NY) LLC Portfolio

REPLIMUNE GROUP INC

EDGEWISE THERAPEUTICS INC

ABIVAX SA

SOLENO THERAPEUTICS INC

COMPASS PATHWAYS PLC

ATAI BECKLEY NV

INVENTIVA SA

MINERVA NEUROSCIENCES INC

PRAXIS PRECISION MEDICINES I

TAYSHA GENE THERAPIES INC

Ally Bridge Group (NY) LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
REPLIMUNE GROUP INC	1200000	11664000	COM
EDGEWISE THERAPEUTICS INC	445000	11042675	COM
ABIVAX SA	70000	9439850	SPONSORED ADS
SOLENO THERAPEUTICS INC	168029	7779743	COM
COMPASS PATHWAYS PLC	1100000	7590000	SPONSORED ADS
ATAI BECKLEY NV	1713105	7006599	SHS
INVENTIVA SA	1500000	6975000	ADS
MINERVA NEUROSCIENCES INC	1655500	6655110	COM NEW
PRAXIS PRECISION MEDICINES I	19882	5860021	COM NEW
TAYSHA GENE THERAPIES INC	957132	5264226	COM SHS
UNIQURE NV	200000	4786000	SHS
EUPRAXIA PHARMACEUTICALS INC	397895	3004107	COM
OVID THERAPEUTICS INC	1785000	2909550	COM
SOLID BIOSCIENCES INC	413625	2332845	COM NEW
WHITEHAWK THERAPEUTICS INC	817939	1979412	COM
PROMIS NEUROSCIENCES INC	249339	1701739	COM SHS